Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models

Date

2016-11-01

Author

Yilmaz, Cigdem
Apak, Aycan
Ozcengiz, Erkan
Özcengiz, Gülay

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

136
views

0
downloads

Whooping cough (pertussis) is a highly contagious respiratory infection caused by Bordetella pertussis. Although availability of effective pertussis vaccines reportedly decreases the incidence of the disease, B. pertussis circulation in populations has not been eliminated. Thus, it is necessary to find new protein candidates with greater immune protective capacities than the currently available acellular pertussis vaccines. In this study, iron superoxide dismutase (FeSOD) gene (sodB) was cloned, expressed in Escherichia coli and recombinant FeSOD protein thence purified. The recombinant protein (rFeSOD) was formulated with aluminum hydroxide (Alum) or monophosphoryl lipid A (MPLA) and injected intraperitoneally to immunize mice, after which IgG1, IgG2a and IFN-gamma titers were measured to assess humoral and cellular responses, respectively, to these immunizations. The extent of bacterial colonization in lungs of intranasally challenged mice was determined 5, 8 and 14 days post-challenge. IgG1 and IgG2a responses were significantly stronger in mice that had been immunized with rFeSOD-MPLA than in those that had received rFeSOD-Alum (P<0.05).Additionally, IgG2a titers were higher in mice vaccinated with recombinant protein FeSOD (rFeSOD) formulated with MPLA, especially after the second immunization. Immunization with rFeSOD-MPLA also provided a modest, but significant decrease in bacterial counts in lungs of mice (P<0.05). Antigen specific-IFN-gamma responses were significantly stronger in the group vaccinated with rFeSOD-MPLA, which could account for the lower bacterial counts. These findings suggest that rFeSOD protein formulated with MPLA has potential as an acellular pertussis vaccine candidate component.

Subject Keywords

Immunology, Microbiology, Virology

URI

https://hdl.handle.net/11511/47010

Journal

MICROBIOLOGY AND IMMUNOLOGY

DOI

https://doi.org/10.1111/1348-0421.12445

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Immune responses against the recombinant FimX and putative peptidyl-prolyl cis-trans isomerase from Bordetella pertussis Yılmaz, Çiğdem; Özcengiz, Gülay; Department of Biology (2011) Whooping cough (pertussis) is a highly contagious respiratory infection caused by Bordetella pertussis. It becomes widespread among adolescent and adults as well as infants. Although availability of effective pertussis vaccines seems to decrease the incidence of the disease, B. pertussis circulation in population has not been eliminated. It is thought that the antigenic drifts in major protective antigens and continued circulation of B. pertussis strains will result in gradual loss of the efficacy of the cu...
Assessment of immune protective capacity of the recombinant iron-superoxide dismutase (fesod) from bordetella pertussis Apak, Aycan; Özcengiz, Gülay; Department of Biology (2011) Whooping cough (pertussis) is a highly contagious acute respiratory disease caused by the strict human pathogen Bordetella pertussis, a gram-negative coccobacillus. The worldwide mass-vaccination was started in 1940s and to date, a number of whole-cell (Pw) and acellular pertussis vaccine (Pa) formulations were developed. Yet the current vaccines are incapable of providing sustained, lifelong immunity and eliminating subclinical infections, which pose a threat especially for unimmunized infants as well as a...
Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins Altindis, Emrah; Tefon, Burcu E.; Yildirim, Volkan; Ozcengiz, Erkan; Becher, Doete; Hecker, Michael; Özcengiz, Gülay (Elsevier BV, 2009-01-22) Bordetella pertussis is the causative agent of highly communicable respiratory infection whooping cough (pertussis) which remains one of the world's leading causes of vaccine-preventable deaths. In the present study, total soluble proteins extracted from two B. pertussis strains, Tohama I and the local isolate Saadet were separated by two-dimensional gel electrophoresis and analyzed by Western blotting for their reactivity with the antisera obtained from the mice immunized with inactivated whole cells as we...
CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. Ito, S; Ishii, KJ; Gürsel, Mayda; Shirotra, H; Ihata, A; Klinman, DM (The American Association of Immunologists, 2005-01-15) Infection by Listeria monocytogenes causes serious morbidity and mortality during the neonatal period. Previous studies established that immunostimulatory CpG oligodeoxynucleotides (ODN) can increased the resistance of adult mice to many infectious pathogens, including Listeria. This work examines the capacity of CpG ODN to stimulate a protective immune response in newborns. Results indicate that dendritic cells, macrophages, and B cells from 3-day-old mice respond to CpG stimulation by secreting IFN- , IL-...
Investigation on immunoprotectivity of recombinant vaccine candidates glutamine-binding periplasmic protein and putative peptidoglycan-binding protein in mouse model Çiçek, Mustafa; Özcengiz, Gülay; Özcengiz, Erkan; Department of Biotechnology (2014) Bordetella pertussis is a gram negative coccobacillus that causes pertussis known as whooping cough. After mass-vaccination started in 1940s, incidence of the disease has decreased. However, B. pertussis circulation in population has not been prevented completely. Starting from the first vaccination, development of several vaccines have been performed. These whole cell (Pw) and acellular pertussis (Pa) vaccines are not completely effective in terms of sustained, lifelong immunity and thus failure in elimina...

Citation Formats

C. Yilmaz, A. Apak, E. Ozcengiz, and G. Özcengiz, “Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models,” MICROBIOLOGY AND IMMUNOLOGY, pp. 717–724, 2016, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/47010.